Literature DB >> 20823213

The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis.

Anna M Ritzman1, Jennifer M Hughes-Hanks, Victoria A Blaho, Laura E Wax, William J Mitchell, Charles R Brown.   

Abstract

Deletion of the chemokine receptor CXCR2 prevents the recruitment of neutrophils into tissues and subsequent development of experimental Lyme arthritis. Following footpad inoculation of Borrelia burgdorferi, the agent of Lyme disease, expression of the CXCR2 ligand KC (CXCL1) is highly upregulated in the joints of arthritis-susceptible mice and is likely to play an important role in the recruitment of neutrophils to the site of infection. To test this hypothesis, we infected C3H KC(-/-) mice with B. burgdorferi and followed the development of arthritis and carditis. Ankle swelling was significantly attenuated during the peak of arthritis in the KC(-/-) mice. Arthritis severity scores were significantly lower in the KC(-/-) mice on days 11 and 21 postinfection, with fewer neutrophils present in the inflammatory lesions. Cardiac lesions were also significantly decreased in KC(-/-) mice at day 21 postinfection. There were, however, no differences between C3H wild-type and KC(-/-) mice in spirochete clearance from tissues. Two other CXCR2 ligands, LIX (CXCL5) and MIP-2 (CXCL2), were not increased to compensate for the loss of KC, and the production of several innate cytokines was unaltered. These results demonstrate that KC plays a critical nonredundant role in the development of experimental Lyme arthritis and carditis via CXCR2-mediated recruitment of neutrophils into the site of infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20823213      PMCID: PMC2976349          DOI: 10.1128/IAI.00798-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

1.  Stat1 deficiency exacerbates carditis but not arthritis during experimental lyme borreliosis.

Authors:  Charles R Brown; Victoria A Blaho; Kevin L Fritsche; Christie M Loiacono
Journal:  J Interferon Cytokine Res       Date:  2006-06       Impact factor: 2.607

2.  Increasing the recruitment of neutrophils to the site of infection dramatically attenuates Borrelia burgdorferi infectivity.

Authors:  Qilong Xu; Sunita V Seemanapalli; Kathryn E Reif; Charles R Brown; Fang Ting Liang
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

3.  Recruitment of macrophages and polymorphonuclear leukocytes in Lyme carditis.

Authors:  Ruth R Montgomery; Carmen J Booth; Xiaomei Wang; Victoria A Blaho; Stephen E Malawista; Charles R Brown
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

4.  Aggravated Lyme carditis in CD11a-/- and CD11c-/- mice.

Authors:  Mireia Guerau-de-Arellano; Joseph Alroy; Daniel Bullard; Brigitte T Huber
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

5.  The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature.

Authors:  Fernanda M Coelho; Vanessa Pinho; Flávio A Amaral; Daniela Sachs; Vívian V Costa; David H Rodrigues; Angélica T Vieira; Tarcília A Silva; Daniele G Souza; Riccardo Bertini; Antônio L Teixeira; Mauro M Teixeira
Journal:  Arthritis Rheum       Date:  2008-08

6.  Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats.

Authors:  M M Barsante; T M Cunha; M Allegretti; F Cattani; F Policani; C Bizzarri; W L Tafuri; S Poole; F Q Cunha; R Bertini; M M Teixeira
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

7.  CXCR2-specific chemokines mediate leukotriene B4-dependent recruitment of neutrophils to inflamed joints in mice with antigen-induced arthritis.

Authors:  Renata Grespan; Sandra Y Fukada; Henrique P Lemos; Silvio M Vieira; Marcelo H Napimoga; Mauro M Teixeira; Alasdair R Fraser; Foo Y Liew; Iain B McInnes; Fernando Q Cunha
Journal:  Arthritis Rheum       Date:  2008-07

8.  Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial.

Authors:  Clarissa E Vergunst; Daniëlle M Gerlag; Luba Lopatinskaya; L Klareskog; M D Smith; F van den Bosch; Huib J Dinant; Yih Lee; Timothy Wyant; Eric W Jacobson; Dominique Baeten; Paul P Tak
Journal:  Arthritis Rheum       Date:  2008-07

9.  Mast cell deficiency in Kit(W-sh) mice does not impair antibody-mediated arthritis.

Authors:  Joseph S Zhou; Wei Xing; Daniel S Friend; K Frank Austen; Howard R Katz
Journal:  J Exp Med       Date:  2007-11-06       Impact factor: 14.307

10.  Expression and function of junctional adhesion molecule-C in human and experimental arthritis.

Authors:  Gaby Palmer; Nathalie Busso; Michel Aurrand-Lions; Dominique Talabot-Ayer; Véronique Chobaz-Péclat; Claudia Zimmerli; Philippe Hammel; Beat A Imhof; Cem Gabay
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  56 in total

1.  5-Lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis.

Authors:  Victoria A Blaho; Yan Zhang; Jennifer M Hughes-Hanks; Charles R Brown
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

Review 2.  The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions.

Authors:  Antonio Citro; Elisa Cantarelli; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

3.  Clindamycin inhibits nociceptive response by reducing tumor necrosis factor-α and CXCL-1 production and activating opioidergic mechanisms.

Authors:  Felipe F Rodrigues; Marcela I Morais; Ivo S F Melo; Paulo S A Augusto; Marcela M G B Dutra; Sarah O A M Costa; Fábio C Costa; Franciele A Goulart; Alysson V Braga; Márcio M Coelho; Renes R Machado
Journal:  Inflammopharmacology       Date:  2019-11-25       Impact factor: 4.473

4.  Infection of Interleukin 17 Receptor A-Deficient C3H Mice with Borrelia burgdorferi Does Not Affect Their Development of Lyme Arthritis and Carditis.

Authors:  Carrie E Lasky; Kara E Jamison; Darcie R Sidelinger; Carmela L Pratt; Guoquan Zhang; Charles R Brown
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

5.  BB0744 Affects Tissue Tropism and Spatial Distribution of Borrelia burgdorferi.

Authors:  Beau Wager; Dana K Shaw; Ashley M Groshong; Jon S Blevins; Jon T Skare
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

6.  Commensal bacteria-dependent select expression of CXCL2 contributes to periodontal tissue homeostasis.

Authors:  Camille Zenobia; Xiao Long Luo; Ahmed Hashim; Toshiharu Abe; Lijian Jin; Yucheng Chang; Zhi Chao Jin; Jian Xun Sun; George Hajishengallis; Mike A Curtis; Richard P Darveau
Journal:  Cell Microbiol       Date:  2013-03-22       Impact factor: 3.715

7.  Coinfection with an intestinal helminth impairs host innate immunity against Salmonella enterica serovar Typhimurium and exacerbates intestinal inflammation in mice.

Authors:  Libo Su; Chien-wen Su; Yujuan Qi; Guilian Yang; Mei Zhang; Bobby J Cherayil; Xichen Zhang; Hai Ning Shi
Journal:  Infect Immun       Date:  2014-06-30       Impact factor: 3.441

8.  Active bacterial modification of the host environment through RNA polymerase II inhibition.

Authors:  Inès Ambite; Nina A Filenko; Elisabed Zaldastanishvili; Daniel Sc Butler; Thi Hien Tran; Arunima Chaudhuri; Parisa Esmaeili; Shahram Ahmadi; Sanchari Paul; Björn Wullt; Johannes Putze; Swaine L Chen; Ulrich Dobrindt; Catharina Svanborg
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

9.  Distinct Roles of Vaccinia Virus NF-κB Inhibitor Proteins A52, B15, and K7 in the Immune Response.

Authors:  Mauro Di Pilato; Ernesto Mejías-Pérez; Carlos Oscar S Sorzano; Mariano Esteban
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

10.  CXCR2 Mediates Brucella-Induced Arthritis in Interferon γ-Deficient Mice.

Authors:  Carolyn A Lacey; Lauren L Keleher; William J Mitchell; Charles R Brown; Jerod A Skyberg
Journal:  J Infect Dis       Date:  2016-03-06       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.